AXSM

NASDAQStock

Axsome Therapeutics, Inc.

$154.97-4.59 (-2.88%)

52-Week Range

$95.65
$189.10

Key Stats

Market Cap

7.9B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.49

Volume

584.9K

Avg Volume

594.8K

Performance

1M

-13.46%

3M

+7.65%

6M

+36.59%

YTD

-10.74%

1Y

+33.53%

3Y

+162.08%

5Y

+144.56%

Price Chart

ETF Exposure

AXSM is held by 92 ETFs

ETFFund NameWeight
VHTVanguard Health Care ETF0.10%
VXFVanguard Extended Market ETF0.10%
TNXTT. Rowe Price Innovation Leaders ETF0.09%
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.09%
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.08%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.05%
WSMLiShares MSCI World Small-Cap ETF0.05%
SMMDiShares Russell 2500 ETF0.05%
JHMMJohn Hancock Investments - Multifactor Mid Cap ETF0.04%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.04%
AVIEAvantis Inflation Focused Equity ETF0.03%
HDGProShares - Hedge Replication ETF0.03%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.02%
BALIiShares U.S. Large Cap Premium Income Active ETF0.02%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.01%
ESGVVanguard ESG U.S. Stock ETF0.01%
VTIVanguard Total Stock Market ETF0.01%
IALTiShares Systematic Alternatives Active ETF0.01%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.01%
IWViShares Russell 3000 ETF0.01%
SCHBSchwab U.S. Broad Market ETF0.01%
SCHKSchwab 1000 Index ETF0.01%
VTHRVanguard Russell 3000 ETF0.01%
GUSAGoldman Sachs MarketBeta US 1000 Equity ETF0.01%
V3AL.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.01%
VTVanguard Total World Stock ETF0.01%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
PreviousPage 2 of 2

About AXSM ETF Exposure

Axsome Therapeutics, Inc. (AXSM) is held by 92 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 7.9B, AXSM is a widely held institutional stock. The stock currently trades at $154.97. Investors can gain exposure to AXSM through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AXSM, sorted by portfolio weight.